Literature DB >> 26256418

Early detection with the β-LACTA™ test of extended-spectrum β-lactamase-producing Enterobacteriaceae in blood cultures.

V Walewski1, I Podglajen2, P Lefeuvre3, F Dutasta4, A Neuschwander4, L Tilouche4, E Carbonnelle2, A Ferroni5.   

Abstract

Effective antibiotic therapy is crucial for the outcome of septic patients and requires early diagnosis of β-lactam resistance in cases of Gram-negative bacteremia. Here, we report high sensitivity of the β-LACTA™ test in rapid detection of extended-spectrum β-lactamase-producing Enterobacteriaceae in blood cultures positive for Gram-negative bacilli.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta-lactamin; ESBL; Enterobacteriaceae; antibiotic resistance; rapid diagnostic test

Mesh：

Substances：

Year:  2015        PMID： 26256418     DOI： 10.1016/j.diagmicrobio.2015.07.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  5 in total

1.  Evaluation of the β-Lacta Test for Detection of Extended-Spectrum-β-Lactamase (ESBL)-Producing Organisms Directly from Positive Blood Cultures by Use of Smudge Plates.

Authors:  Maan Hasso; Vanessa Porter; Andrew E Simor
Journal:  J Clin Microbiol       Date:  2017-10-11       Impact factor: 5.948

2.  Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study.

Authors:  Marc Garnier; Sacha Rozencwajg; Tài Pham; Sophie Vimont; Clarisse Blayau; Mehdi Hafiani; Jean-Pierre Fulgencio; Francis Bonnet; Jean-Luc Mainardi; Guillaume Arlet; Muriel Fartoukh; Salah Gallah; Christophe Quesnel
Journal:  Crit Care       Date:  2017-06-28       Impact factor: 9.097

3.  Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS.

Authors:  Léa Ponderand; Patricia Pavese; Danièle Maubon; Emmanuelle Giraudon; Thomas Girard; Caroline Landelle; Max Maurin; Yvan Caspar
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-12-09       Impact factor: 3.944

4.  Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.

Authors:  Alexia Verroken; Lydwine Defourny; Olivier le Polain de Waroux; Leïla Belkhir; Pierre-François Laterre; Michel Delmée; Youri Glupczynski
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

5.  Evaluation of Two Methods for the Detection of Third Generation Cephalosporins Resistant Enterobacterales Directly From Positive Blood Cultures.

Authors:  Clarisse Durand; Agathe Boudet; Jean-Philippe Lavigne; Alix Pantel
Journal:  Front Cell Infect Microbiol       Date:  2020-09-11       Impact factor: 5.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.